Abstract
Low-dose aspirin reduces colorectal cancer (CRC) incidence and mortality. Recently, the aspirin effect has been shown to occur primarily in the proximal colon. Colonoscopy has been either less effective or ineffective in the proximal compared to the distal colon. The authors assessed the cost-effectiveness of adding low-dose aspirin to a simulated screening with colonoscopy or sigmoidoscopy.
Lingua originale | English |
---|---|
pagine (da-a) | 1172-1179 |
Numero di pagine | 8 |
Rivista | EGUT |
Volume | 61 |
DOI | |
Stato di pubblicazione | Pubblicato - 2012 |
Pubblicato esternamente | Sì |
Keywords
- Administration, Oral
- Aged
- Aged, 80 and over
- Anti-Inflammatory Agents, Non-Steroidal
- Aspirin
- Colonoscopy
- Colorectal Neoplasms
- Cost-Benefit Analysis
- Dose-Response Relationship, Drug
- Humans
- Male
- Mass Screening
- Middle Aged
- Neoplasm Staging
- Primary Prevention
- Treatment Outcome